German firm to offer implant removal device:
This article was originally published in Clinica
Executive Summary
EMS Medical, based in Konstanz, Germany, hopes to begin selling its endoscopic, ballistically-driven cement removal system for extracting non-cemented hip and knee components, following a successful multicentre European study. The Swiss OrthoClast system has been sold worldwide for more than a year for safely and effectively removing cement during implant revision procedures. The new indication - removal of porous coated components such as hip cups and stems and knee prostheses - will likely be available in June. The company is looking for a US distributor.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.